Stryker Corporation

Stryker Corporation

287.10
EUR
-3.90
(-1.34%)
8.28EPS
Feb 02Next Earn
Stryker Corporation
BSEBG:SYK
(Bulgarian Stock Exchange)

Recent

price

287.10

P/E

ratio

- -

div

yld

1.07%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
18.47
21.49
22.75
23.83
25.56
26.41
30.27
33.27
36.36
39.8
38.22
45.38
48.78
54
59.3
65.71
68.71
Revenue per Share
3.21
3.48
3.41
2.66
1.36
3.82
4.4
2.73
9.5
5.57
4.26
5.29
6.23
8.34
7.86
8.49
9.47
Basic EPS, GAAP
3.44
3.13
3.8
4.47
4.09
1.89
3.81
2.57
5.45
4.12
7.43
7.26
5.38
8.26
9.15
11.21
11.95
Free Cash Flow per Basic Share
0.6
0.72
0.85
1.06
1.22
1.38
1.52
1.7
1.88
2.08
2.3
2.52
2.78
3
3.2
3.36
3.48
Dividend per Share
18.34
20.17
22.62
23.93
22.74
22.82
25.47
26.62
31.33
34.2
34.79
39.41
43.88
48.92
54.1
58.61
61.62
Book Value per Share
13.8
10.94
13.24
8.5
6.33
6.92
-0.84
-1.81
-2.66
-1.31
-13.95
-7.63
-8.32
-3.27
1.01
-6.67
-3.71
Tangible Book Value per Share
396
386
381
379
378
377
374
374
374
374
375
377
378
380
381
382
383
Basic Weighted Avg Shares
7,320
8,307
8,657
9,021
9,675
9,946
11,325
12,444
13,601
14,884
14,351
17,108
18,449
20,498
22,595
25,116
26,300
Sales/Revenue/Turnover
25.61
21.21
22.12
20.82
20.74
21.69
20.6
19.85
18.82
19.52
15.61
15.71
16.86
19.14
20.65
20.14
21.8
Operating Margin (%)
223
282
277
307
378
397
546
642
723
778
812
990
998
1,028
1,050
1,193
1,207
Depreciation Expense
1,273
1,345
1,298
1,006
515
1,439
1,647
1,020
3,553
2,083
1,599
1,994
2,358
3,165
2,993
3,246
3,623
Net Income, GAAP
26.37
20.23
23.87
17
55.6
17.06
14.26
50.56
- -
18.7
18.17
12.58
12.11
13.83
14.29
28.09
29.18
Effective Tax Rate (%)
17.39
16.19
14.99
11.15
5.32
14.47
14.54
8.2
26.12
13.99
11.14
11.66
12.78
15.44
13.25
12.92
13.78
Profit Margin (%)
6,027
5,367
6,272
5,678
4,223
4,441
4,713
4,508
4,926
6,658
4,666
5,468
3,972
4,597
7,231
6,961
7,683
Working Capital
996
1,751
1,746
2,739
3,246
3,230
6,686
6,590
8,486
10,231
13,230
12,472
11,857
10,901
12,188
14,859
14,176
LT Debt
7,174
7,683
8,597
9,047
8,595
8,511
9,550
9,980
11,730
12,807
13,084
14,877
16,616
18,593
20,634
22,420
23,457
Total Equity
17.27
15.17
13.31
9.37
4.48
12.14
12.84
6.73
- -
9.66
7.12
8.28
8.73
10.88
9.53
9.63
10.06
Return on Invested Capital (%)
17.19
15.55
13.1
9.08
4.22
11.48
11.37
6.06
- -
9.16
6.27
7.33
8.27
11.36
10.16
10.16
10.24
Return on Capital (%)
18.49
18.11
15.95
11.4
5.84
16.82
18.24
10.45
32.75
16.98
12.35
14.26
14.97
17.98
15.26
15.08
16.02
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
499
750
754
LT Borrowings
14,224
14,192
14,176
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
383
384
381
Market Capitalization
- -
- -
- -

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
13,338
14,418
14,183
Cash, Cash Equivalents & STI
2,965
3,476
3,271
Accounts Receivable, Net
3,571
3,743
3,693
Inventories
5,419
5,521
5,747
Total Current Liabilities
6,315
6,684
6,500
Payables & Accruals
4,931
4,829
4,383
ST Debt
499
750
754
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.25%
11.39%
8.66%
Free Cash Flow
29.71%
12.11%
22.83%
Net Income, GAAP
24.03%
16.04%
8.45%
Sales/Revenue/Turnover
9.84%
11.91%
11.16%
Total Cash Common Dividend
9.46%
8.29%
5.33%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,243
5,422
5,494
6,436
22,595
2025
5,866
6,022
6,057
7,171
25,116
2026
6,020
6,589
6,520
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.07
2.17
2.19
1.43
7.86
2025
1.71
2.31
2.25
2.22
8.49
2026
1.95
3.33
1.97
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.8
0.8
0.8
0.8
3.2
2025
0.84
0.84
0.84
0.84
3.36
2026
0.88
0.88
0.88
- -
- -
Business
Stryker Corporation (NYSE: SYK) develops, manufactures, and markets medical technologies, including orthopedic implants and instruments; surgical equipment and navigation systems; endoscopic and communications products; and patient handling and emergency medical equipment. The company offers its Mako robotic-arm assisted surgery platform for orthopedic procedures; Triathlon and Trident hip and knee systems; Gamma3 and T2 intramedullary nailing systems; and Ceros and Variax distal fixation systems, among other specialized devices for joint reconstruction, trauma and extremities, and spine care. Stryker provides interventional devices, including embolic products and guidewires, along with neurotechnology and spine products such as Vizor vision systems and SurgiCount safety sponges; it also delivers solutions for operating room integration and capital equipment. Founded in 1941 and headquartered in Kalamazoo, Michigan, the company operates globally across the Americas, Europe, Asia-Pacific, and other regions, serving hospitals, ambulatory surgery centers, and healthcare providers in the medtech industry. In recent developments, Stryker completed the acquisition of Artelon AB in September 2024, enhancing its sports medicine portfolio with advanced biomaterials for soft tissue regeneration. The company also acquired Wright Medical Group N.V. in 2022, bolstering its extremity reconstruction offerings, and continues to expand through strategic investments, including a new manufacturing facility in Ireland to support European growth. Additionally, Stryker launched the next-generation Mako Total Knee 2.0 application and advanced its Blue Seal bipolar sealer technology, reflecting ongoing innovation in robotics and surgical efficiency amid robust demand in orthopedics and neurotechnology segments.

Company News

  • GEHC or SYK: Which Is the Better Value Stock Right Now?

  • Stryker announces intention to nominate Jim Davis to board of directors

  • Stryker Corporation $SYK Stock: Commonwealth Equity Services LLC Trims Position

  • Stryker Corporation $SYK Shares Sold by Chicago Partners Investment Group LLC

  • Stryker Corporation $SYK Shares Sold by Candriam S.C.A.

  • 3 Medical Device Stocks That Keep Raising Dividends. One Just Hit 55 Years

  • Diamond Hill Large Cap Fund Q3 2026 Portfolio Update

  • 3,649 Stryker Corporation $SYK Shares Sold by Boston Trust Walden Corp

  • Stryker Corporation $SYK Stock Bought by International Assets Investment Management LLC

  • SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook Cut

  • Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS

  • SYK Q3 Earnings Call Highlights Softer Demand and Revised Outlook

  • What Stryker (SYK) Said on Its Q3 Earnings Call

  • Stryker Analysts Cut Their Forecasts Following Downbeat Q3 Earnings

  • Stryker's Guidance Cut Rattles Investors: What It Really Says About 2027

  • Stryker Corporation (SYK) Q3 2026 Earnings Call Transcript

  • Stryker (SYK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

  • Stryker (SYK) Q3 Earnings and Revenues Lag Estimates

  • Stryker Q3 2026 Earnings Call Transcript

  • Stryker reports third quarter 2026 operating results